Screener
Assembly Biosciences ASMB Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other income | ||
| Interest and other income, net | 2,291 | 1,123 |
| Total other income | 2,291 | 1,123 |
| Net loss | $(9,079) | $(8,818) |
| Other comprehensive loss | ||
| Unrealized loss on marketable securities | 327 | 42 |
| Comprehensive loss | $(9,406) | $(8,860) |
| Net loss per share, basic and diluted | $(0.54) | $(1.17) |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's net income?
- Assembly Biosciences (ASMB) reported net income of -$9.08M in Q1 2026.
- How has Assembly Biosciences's net income changed year-over-year?
- Assembly Biosciences's net income decreased by 3.0% year-over-year, from -$8.82M to -$9.08M.
- What is the long-term trend for Assembly Biosciences's net income?
- Over 3 years (2021 to 2024), Assembly Biosciences's net income has grown at a -32.4% compound annual growth rate (CAGR), from -$129.86M to -$40.18M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Assembly Biosciences's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude